BBL
ABBV icon

Beck Bode LLC’s AbbVie ABBV Stock Holding History

Beck Bode LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-43,175
Closed -$7.41M – 104
2024
Q2 		$7.41M Buy
+43,175
New +$7.15M 1.49% 27
2022
Q3 		– Sell
-9,433
Closed -$1.45M – 225
2022
Q2 		$1.45M Buy
+9,433
New +$1.44M 0.31% 72
2021
Q4 		– Sell
-40,610
Closed -$4.38M – 87
2021
Q3 		$4.38M Sell
40,610
-191
-0.5% -$21.8K 1.22% 31
2021
Q2 		$4.6M Buy
+40,801
New +$4.6M 1.27% 33
2020
Q4 		– Sell
-600
Closed -$53K – 4
2020
Q3 		$53K Sell
600
-1,967
-77% -$185K 0.02% 103
2020
Q2 		$252K Buy
2,567
+43
+2% +$3.79K 0.1% 48
2020
Q1 		$207K Buy
+2,524
New +$215K 0.1% 52
2019
Q1 		– Sell
-21,381
Closed -$1.97M – 65
2018
Q4 		$1.97M Buy
+21,381
New +$1.88M 1.07% 32

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Beck Bode LLC's ABBV Position: Q3 2024 in Review

Beck Bode LLC sold out of AbbVie (ABBV) in Q3 2024, closing a stake of 43,175 shares — an estimated $7.41M sold.

Beck Bode LLC first reported a position in ABBV in Q4 2018 and held it in 8 quarters. The position peaked at $7.41M in Q2 2024. 3,505 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

  • Beck Bode LLC reported no remaining AbbVie position as of Q3 2024 after selling out during the quarter.
  • Beck Bode LLC sold 43,175 AbbVie shares in Q3 2024, an estimated $7.41M.
  • Beck Bode LLC first reported a position in AbbVie in Q4 2018 and held it in 8 quarters.
  • Beck Bode LLC's AbbVie position peaked at $7.41M in Q2 2024.
  • 3,505 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on Beck Bode LLC's 13F filing for Q3 2024, filed 12 Nov 2024.